Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pintos

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Anales De Pediatria (Barcelona, Spain : 2003)|April 13, 2011
[Sotos syndrome: a novel nonsense mutation in NSD1 gene, presenting with neonatal cutis laxa]E Cortès-Saladelafont, K Arias-Sáez, D Esteban-Oliva, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 26, 2006
Enzyme replacement therapy with agalsidase alfa in children with Fabry diseaseU Ramaswami, S Wendt, G Pintos-Morell, et al.
Journal of Inherited Metabolic Disease|January 1, 1995
Molybdenum cofactor deficiency associated with Dandy-Walker malformationG Pintos-Morell, M A Naranjo, M Artigas, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|March 9, 2004
[Surgical treatment of a pheocromocytoma bilateral in a 5 year old patient with the von Hippel-Lindau disease]J A Blanco, D Blanco, A Alastrue, et al.
Anales Espanoles De Pediatria|July 1, 1996
[Neonatal hemolytic-uremic syndrome associated with methylmalonic aciduria and homocystinuria]M Rogé Canales, C Rodrigo Gonzalo de Liria, L J Prats Viñas, et al.
European Journal of Medical Genetics|August 17, 2010
First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS)C Alcalde-Martín, J M Muro-Tudelilla, R Cancho-Candela, et al.
The British Journal of Dermatology|June 19, 2007
Fabry disease and the skin: data from FOS, the Fabry outcome surveyC H Orteu, T Jansen, O Lidove, et al.
Microbial Pathogenesis|January 29, 2016
Influence of Melaleuca alternifolia oil nanoparticles on aspects of Pseudomonas aeruginosa biofilmVanessa M Comin, Leonardo Q S Lopes, Priscilla M Quatrin, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|September 4, 2010
[Recommendations and management of type I hereditary or hepatorenal tyrosinemia]M L Couce, L Aldámiz-Echevarría, A Baldellou, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Anales De Pediatria (Barcelona, Spain : 2003)|April 13, 2011
[Sotos syndrome: a novel nonsense mutation in NSD1 gene, presenting with neonatal cutis laxa]E Cortès-Saladelafont, K Arias-Sáez, D Esteban-Oliva, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 26, 2006
Enzyme replacement therapy with agalsidase alfa in children with Fabry diseaseU Ramaswami, S Wendt, G Pintos-Morell, et al.
Journal of Inherited Metabolic Disease|January 1, 1995
Molybdenum cofactor deficiency associated with Dandy-Walker malformationG Pintos-Morell, M A Naranjo, M Artigas, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|March 9, 2004
[Surgical treatment of a pheocromocytoma bilateral in a 5 year old patient with the von Hippel-Lindau disease]J A Blanco, D Blanco, A Alastrue, et al.
Anales Espanoles De Pediatria|July 1, 1996
[Neonatal hemolytic-uremic syndrome associated with methylmalonic aciduria and homocystinuria]M Rogé Canales, C Rodrigo Gonzalo de Liria, L J Prats Viñas, et al.
European Journal of Medical Genetics|August 17, 2010
First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS)C Alcalde-Martín, J M Muro-Tudelilla, R Cancho-Candela, et al.
The British Journal of Dermatology|June 19, 2007
Fabry disease and the skin: data from FOS, the Fabry outcome surveyC H Orteu, T Jansen, O Lidove, et al.
Microbial Pathogenesis|January 29, 2016
Influence of Melaleuca alternifolia oil nanoparticles on aspects of Pseudomonas aeruginosa biofilmVanessa M Comin, Leonardo Q S Lopes, Priscilla M Quatrin, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|September 4, 2010
[Recommendations and management of type I hereditary or hepatorenal tyrosinemia]M L Couce, L Aldámiz-Echevarría, A Baldellou, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 4